Why TransMedics Remains A Buy Into 2026

Company Overview - TransMedics Inc. (NASDAQ: TMDX) is involved in the design, manufacturing, and selling of organ care systems (OCS) [1] - The stock price experienced a significant increase of 53% from April 23 to its interim high on June 11, followed by a decline of 25%, bringing the current price to $108 [1] Stock Performance - The stock rose to an interim high on June 11, indicating strong market interest and performance during that period [1] - The subsequent decline of 25% suggests volatility and potential market corrections following the peak [1]